{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:56:10Z","timestamp":1791219370013,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG078109"],"award-info":[{"award-number":["U19AG078109"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["1267001"],"award-info":[{"award-number":["1267001"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Alzheimer\u2019s disease and related dementias are major public health challenges, with the apolipoprotein (<jats:italic>APOE<\/jats:italic>) \u03b54 allele being a significant genetic risk factor. Cardiometabolic risk factors such as diabetes, hypertension, dyslipidemia, obesity, and tobacco use are also linked to cognitive impairment. The objective of this study was to (1) characterize both independent and interactive associations of racial\/ethnic group (Non-Hispanic White (NHW), Non-Hispanic Black (NHB) and Hispanic), APOE \u03b54 genotype, and multiple cardiometabolic risk factors with performance across four cognitive domains. Secondarily, we aimed to quantify the hypothetical population-level cognitive gains that could result from eliminating each modifiable risk factor within each racial\/ethnic group.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed baseline data from 3,833 HABS-HD participants (1,348 NHW; 1,065 NHB; 1,420 Hispanic; mean age 65.3\u2009\u00b1\u20098.6\u00a0years; 62.0% female). APOE genotype, consensus-determined cardiometabolic status, and harmonized cognitive domain scores (episodic memory, executive function, processing speed, language) were obtained. Multivariable linear regressions assessed independent effects of race\/ethnicity, APOE \u03b54 carriage, and each cardiometabolic factor on domain-specific\u00a0z-scores, adjusting for age, sex, and education (Bonferroni-corrected). Interaction terms tested effect modification by race\/ethnicity. Counterfactual population intervention models estimated the mean cognitive gain from hypothetically eliminating each modifiable risk factor within each racial\/ethnic group.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>NHB Hispanic, and NHW participants prevalences were\u00a0APOE \u03b54 (32.2%, 27.4%, 17.6%), diabetes (26.1%, 35.0%, 13.9%), hypertension (79.0%, 63.6%,\u00a058.2%), obesity (56.8%, 50.3%,\u00a038.5%), and tobacco dependence (12.9%, 7.5%, 3.9%). In adjusted models, NHB and Hispanic ethnicity, APOE \u03b54, diabetes, hypertension, and tobacco dependence each independently predicted lower performance across all four cognitive domains (adjusted <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001), whereas obesity showed domain-specific positive associations. No race\u2009\u00d7\u2009risk-factor interactions remained significant after correction. In intervention models, hypothetically eliminating diabetes and hypertension yielded the largest predicted improvements, especially in executive function and language, with the greatest gains projected among NHB and Hispanic racial ethnic group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Cardiometabolic health markedly contributes to racial ethnic differences in cognitive aging beyond <jats:italic>APOE<\/jats:italic> \u03b54 effects. Population-level interventions targeting diabetes and hypertension could narrow NHB and Hispanic cognitive deficits, informing precision public-health strategies for dementia prevention.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-025-01866-9","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:43:14Z","timestamp":1759315394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Population intervention models of racial ethnic disparities in cognitive outcomes from cardiometabolic risk factors \u2013 HABS-HD"],"prefix":"10.1186","volume":"17","author":[{"given":"Cellas A.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubnaa","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Gills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Odden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Health and Aging Brain Study (HABS-HD) Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"1866_CR1","doi-asserted-by":"publisher","unstructured":"2025 Alzheimer's disease facts and figures. Alzheimers Dement. 2025;21(4):e70235. https:\/\/doi.org\/10.1002\/alz.70235.","DOI":"10.1002\/alz.70235"},{"issue":"8","key":"1866_CR2","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s & Dementia. 2024Aug;20(8):5143\u201369.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"5","key":"1866_CR3","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/alz.12831","volume":"19","author":"AJ Polsinelli","year":"2023","unstructured":"Polsinelli AJ, Logan PE, Lane KA, Manchella MK, Nemes S, Sanjay AB, et al. Apoe \u03b54 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(5):1983\u201393.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1866_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13195-021-00855-y","volume":"13","author":"MA Beydoun","year":"2021","unstructured":"Beydoun MA, Weiss J, Beydoun HA, Hossain S, Maldonado AI, Shen B, et al. Race, APOE genotypes, and cognitive decline among middle-aged urban adults. Alzheimers Res Ther. 2021Jun 30;13(1):120.","journal-title":"Alzheimers Res Ther"},{"key":"1866_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.735036","volume":"12","author":"DS Powell","year":"2021","unstructured":"Powell DS, Kuo PL, Qureshi R, Coburn SB, Knopman DS, Palta P, et al. The relationship of APOE \u03b54, race, and sex on the age of onset and risk of dementia. Front Neurol. 2021;12:735036.","journal-title":"Front Neurol"},{"issue":"6","key":"1866_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","volume":"11","author":"M Baumgart","year":"2015","unstructured":"Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimer\u2019s & Dementia. 2015Jun;11(6):718\u201326.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"1866_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.dadm.2017.01.005","volume":"7","author":"CY Santos","year":"2017","unstructured":"Santos CY, Snyder PJ, Wu W, Zhang M, Echeverria A, Alber J. Pathophysiologic relationship between Alzheimer\u2019s disease, cerebrovascular disease, and cardiovascular risk: a review and synthesis. Alz & Dem Diag Ass & Dis Mo. 2017Jan;7(1):69\u201387.","journal-title":"Alz & Dem Diag Ass & Dis Mo"},{"issue":"43","key":"1866_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035557","volume":"102","author":"N Aderinto","year":"2023","unstructured":"Aderinto N, Olatunji G, Abdulbasit M, Ashinze P, Faturoti O, Ajagbe A, et al. The impact of diabetes in cognitive impairment: A review of current evidence and prospects for future investigations. Medicine (Baltimore). 2023Oct 27;102(43):e35557.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"1866_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1524-6175.2005.04498.x","volume":"7","author":"A Vicario","year":"2005","unstructured":"Vicario A, Martinez CD, Baretto D, Casale AD, Nicolosi L. Hypertension and cognitive decline: impact on executive function. J Clin Hypertens. 2005;7(10):598\u2013604.","journal-title":"J Clin Hypertens"},{"issue":"2","key":"1866_CR10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/sj.ijo.802225","volume":"27","author":"MF Elias","year":"2003","unstructured":"Elias MF, Elias PK, Sullivan LM, Wolf PA, D\u2019Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes. 2003;27(2):260\u20138.","journal-title":"Int J Obes"},{"issue":"7300","key":"1866_CR11","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","volume":"322","author":"M Kivipelto","year":"2001","unstructured":"Kivipelto M. Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population based study. BMJ. 2001Jun 16;322(7300):1447\u201351.","journal-title":"BMJ"},{"issue":"1","key":"1866_CR12","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.amepre.2016.07.036","volume":"52","author":"J Daw","year":"2017","unstructured":"Daw J. Contribution of four comorbid conditions to racial\/ethnic disparities in mortality risk. Am J Prev Med. 2017;52(1):S95-102.","journal-title":"Am J Prev Med"},{"key":"1866_CR13","doi-asserted-by":"publisher","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart Disease and Stroke Statistics\u20142016 Update: A Report From the American Heart Association. Circulation [Internet]. 2016 Jan 26 [cited 2024 Nov 16];133(4). Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIR.0000000000000350","DOI":"10.1161\/CIR.0000000000000350"},{"key":"1866_CR14","unstructured":"National Center for Health Statistics (US). Health, United States, 2011: With Special Feature on Socioeconomic Status and Health [Internet]. Hyattsville (MD): National Center for Health Statistics (US); 2012 [cited 2024 Nov 16]. (Health, United States). Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK98752\/"},{"issue":"10248","key":"1866_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346.","journal-title":"Lancet"},{"issue":"1","key":"1866_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12202","volume":"13","author":"SE O\u2019Bryant","year":"2021","unstructured":"O\u2019Bryant SE, Johnson LA, Barber RC, Braskie MN, Christian B, Hall JR, et al. The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics. Alz & Dem Diag Ass & Dis Mo. 2021Jan;13(1):e12202.","journal-title":"Alz & Dem Diag Ass & Dis Mo"},{"issue":"15","key":"1866_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.834685","volume":"13","author":"SE O\u2019Bryant","year":"2022","unstructured":"O\u2019Bryant SE, Petersen M, Hall J, Johnson L. APOE\u03b54 genotype is related to brain amyloid among Mexican Americans in the HABS-HD study. Front Neurol. 2022;13(15):834685.","journal-title":"Front Neurol"},{"issue":"5123","key":"1866_CR18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer\u2019s Disease in Late Onset Families. Science. 1993Aug 13;261(5123):921\u20133.","journal-title":"Science"},{"issue":"8","key":"1866_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"16","author":"SB Sando","year":"2008","unstructured":"Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, et al. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway. BMC Neurol. 2008Apr;16(8):9.","journal-title":"BMC Neurol"},{"issue":"5","key":"1866_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70327","volume":"21","author":"CA Hayes","year":"2025","unstructured":"Hayes CA, Odden MC, Vintimilla R, Thorpe RJ. Racial ethnic variations in the cardiometabolic determinants and blood pressure of white matter hyperintensities among females\u2014the HABS-HD study. Alzheimers Dement. 2025;21(5):e70327.","journal-title":"Alzheimers Dement"},{"issue":"S4","key":"1866_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/alz.055620","volume":"17","author":"R Vintimilla","year":"2021","unstructured":"Vintimilla R, Hall JR, Johnson LA, Yaffe K, Toga AW, O\u2019Bryant S, et al. Cardiovascular risk factors, white matter hyperintensities and executive function: Difference among Mexican Americans and non-Hispanic whites. Alzheimer\u2019s & Dementia. 2021Dec;17(S4):e055620.","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"1866_CR22","volume-title":"Wechsler memory scale\u2013third edition (WMS-III)","author":"D Wechsler","year":"1997","unstructured":"Wechsler D. Wechsler memory scale\u2013third edition (WMS-III). San Antonio, TX: The Psychological Corporation; 1997."},{"key":"1866_CR23","unstructured":"Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation. Vol. 4. Neuropsychology press; 1985."},{"issue":"4","key":"1866_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1076\/clin.16.4.439.13908","volume":"16","author":"HM Gonz\u00e1lez","year":"2002","unstructured":"Gonz\u00e1lez HM, Mungas D, Haan MN. A Verbal Learning and Memory Test for English- and Spanish-speaking Older Mexican-American Adults. Clin Neuropsychol. 2002Dec 1;16(4):439\u201351.","journal-title":"Clin Neuropsychol"},{"key":"1866_CR25","volume-title":"Neuropsychological assessment","author":"MD Lezak","year":"2004","unstructured":"Lezak MD. Neuropsychological assessment. USA: Oxford University Press; 2004."},{"key":"1866_CR26","doi-asserted-by":"crossref","unstructured":"O\u2019Bryant SE, Edwards M, Johnson L, Hall J, Gamboa A, O\u2019jile J. Texas Mexican American adult normative studies: Normative data for commonly used clinical neuropsychological measures for English- and Spanish-speakers. Developmental Neuropsychology. 2018:43(1):1\u201326.","DOI":"10.1080\/87565641.2017.1401628"},{"key":"1866_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1627525","author":"LB Abdullah","year":"2025","unstructured":"Abdullah LB, Zhou Z, Alliey NA, Barber R, Hall J, O\u2019Bryant S. Low premorbid IQ may exacerbate the cognitive effects of apolipoprotein \u03b54 (APOE \u03b54): a multi-ethnic cross-sectional study from HABS-HD. Front Neurol. 2025. https:\/\/doi.org\/10.3389\/fneur.2025.1627525. (2025 Jul 11).","journal-title":"Front Neurol"},{"issue":"2","key":"1866_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/0146167292182001","volume":"18","author":"JG Hull","year":"1992","unstructured":"Hull JG, Tedlie JC, Lehn DA. Moderator Variables in Personality Research: The Problem of Controlling for Plausible Alternatives. Pers Soc Psychol Bull. 1992Apr;18(2):115\u20137.","journal-title":"Pers Soc Psychol Bull"},{"issue":"3","key":"1866_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jesp.2003.10.001","volume":"40","author":"VY Yzerbyt","year":"2004","unstructured":"Yzerbyt VY, Muller D, Judd CM. Adjusting researchers\u2019 approach to adjustment: On the use of covariates when testing interactions. J Exp Soc Psychol. 2004May 1;40(3):424\u201331.","journal-title":"J Exp Soc Psychol"},{"issue":"1","key":"1866_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biopsych.2013.09.006","volume":"75","author":"MC Keller","year":"2014","unstructured":"Keller MC. Gene \u00d7 environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol Psychiatry. 2014Jan 1;75(1):18\u201324.","journal-title":"Biol Psychiatry"},{"issue":"01","key":"1866_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/jech.2008.085985","volume":"64","author":"NL Fleischer","year":"2010","unstructured":"Fleischer NL, Fernald LCH, Hubbard AE. Estimating the potential impacts of intervention from observational data: methods for estimating causal attributable risk in a cross-sectional analysis of depressive symptoms in Latin America. J Epidemiol Community Health. 2010Jan 1;64(01):16\u201321.","journal-title":"J Epidemiol Community Health"},{"issue":"7","key":"1866_CR32","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/aje\/kwq472","volume":"173","author":"JM Snowden","year":"2011","unstructured":"Snowden JM, Rose S, Mortimer KM. Implementation of G-Computation on a Simulated Data Set: Demonstration of a Causal Inference Technique. Am J Epidemiol. 2011Apr 1;173(7):731\u20138.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1866_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/EDE.0000000000000648","volume":"28","author":"D Westreich","year":"2017","unstructured":"Westreich D. From Patients to Policy: Population Intervention Effects in Epidemiology. Epidemiology. 2017Jul;28(4):525\u20138.","journal-title":"Epidemiology"},{"key":"1866_CR34","doi-asserted-by":"publisher","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation [Internet]. 2025 Feb 25 [cited 2025 May 1];151(8). Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIR.0000000000001303","DOI":"10.1161\/CIR.0000000000001303"},{"issue":"12","key":"1866_CR35","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1111\/j.1532-5415.2004.52575.x","volume":"52","author":"KM Mehta","year":"2004","unstructured":"Mehta KM, Simonsick EM, Rooks R, Newman AB, Pope SK, Rubin SM, et al. Black and white differences in cognitive function test scores: what explains the difference? J Am Geriatr Soc. 2004;52(12):2120\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1866_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70138","volume":"21","author":"S Barral","year":"2025","unstructured":"Barral S, Yang Z, Phillips N, Barber RC, Brickman AM, Honig LS, et al. APOE and Alzheimer\u2019s disease and related dementias risk among 12,221 Hispanics\/Latinos. Alzheimers Dement. 2025Apr 12;21(4):e70138.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1866_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1017\/S1041610219002175","volume":"33","author":"J Perales-Puchalt","year":"2021","unstructured":"Perales-Puchalt J, Gauthreaux K, Shaw A, McGee JL, Teylan MA, Chan KCG, et al. Risk of mild cognitive impairment among older adults in the United States by ethnoracial group. Int Psychogeriatr. 2021Jan 1;33(1):51\u201362.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1866_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000256662","volume":"34","author":"PA Boyle","year":"2010","unstructured":"Boyle PA, Buchman AS, Wilson RS, Kelly JF, Bennett DA. The APOE \u220a4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology. 2010;34(1):43\u20139.","journal-title":"Neuroepidemiology"},{"issue":"3","key":"1866_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000342778","volume":"40","author":"L Barnes","year":"2013","unstructured":"Barnes L, Arvanitakis Z, Yu L, Kelly J, De Jager P, Bennett D. APOE and Change in Episodic Memory in Blacks and Whites. Neuroepidemiology. 2013;40(3):211\u20139.","journal-title":"Neuroepidemiology"},{"issue":"7","key":"1866_CR40","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/aje\/154.7.635","volume":"154","author":"JA Luchsinger","year":"2001","unstructured":"Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes Mellitus and Risk of Alzheimer\u2019s Disease and Dementia with Stroke in a Multiethnic Cohort. Am J Epidemiol. 2001Oct 1;154(7):635\u201341.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1866_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","volume":"8","author":"TT Van Sloten","year":"2020","unstructured":"Van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020Apr;8(4):325\u201336.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"1866_CR42","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1161\/CIRCULATIONAHA.110.978114","volume":"123","author":"I Hajjar","year":"2011","unstructured":"Hajjar I, Quach L, Yang F, Chaves PHM, Newman AB, Mukamal K, et al. Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the cardiovascular health study. Circulation. 2011;123(8):858\u201365.","journal-title":"Circulation"},{"issue":"4","key":"1866_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1590\/1980-57642016dn11-040008","volume":"11","author":"HCS Muela","year":"2017","unstructured":"Muela HCS, Costa-Hong VA, Yassuda MS, Machado MF, Nogueira RdeC, Moraes NC, et al. Impact of hypertension severity on arterial stiffness, cerebral vasoreactivity, and cognitive performance. Dement Neuropsychol. 2017;11(4):389\u201397.","journal-title":"Dement Neuropsychol"},{"issue":"5","key":"1866_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ajh.2009.35","volume":"22","author":"H Triantafyllidi","year":"2009","unstructured":"Triantafyllidi H, Arvaniti C, Lekakis J, Ikonomidis I, Siafakas N, Tzortzis S, et al. Cognitive impairment is related to increased arterial stiffness and microvascular damage in patients with never-treated essential hypertension. Am J Hypertens. 2009;22(5):525\u201330.","journal-title":"Am J Hypertens"},{"issue":"2","key":"1866_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/gerona\/glx152","volume":"73","author":"Z Arvanitakis","year":"2018","unstructured":"Arvanitakis Z, Capuano AW, Bennett DA, Barnes LL. Body mass index and decline in cognitive function in older Black and White persons. J Gerontol A Biol Sci Med Sci. 2018;73(2):198\u2013203.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"1866_CR46","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1111\/jgs.13111","volume":"62","author":"DA Robertson","year":"2014","unstructured":"Robertson DA, Savva GM, Coen RF, Kenny RA. Cognitive function in the prefrailty and frailty syndrome. J Am Geriatr Soc. 2014;62(11):2118\u201324.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1866_CR47","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000216840","volume":"27","author":"K Martin","year":"2009","unstructured":"Martin K, Thomson R, Blizzard L, Wood A, Garry M, Srikanth V. Visuospatial ability and memory are associated with falls risk in older people: a population-based study. Dement Geriatr Cogn Disord. 2009;27(5):451\u20137.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"7380","key":"1866_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/bmj.326.7380.73","volume":"326","author":"FE Shaw","year":"2003","unstructured":"Shaw FE, Bond J, Richardson DA, Dawson P, Steen IN, McKeith IG, et al. Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial. BMJ. 2003Jan 11;326(7380):73.","journal-title":"BMJ"},{"issue":"6","key":"1866_CR49","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jalz.2012.11.014","volume":"9","author":"E Albanese","year":"2013","unstructured":"Albanese E, Taylor C, Siervo M, Stewart R, Prince MJ, Acosta D. Dementia severity and weight loss: a comparison across eight cohorts. Alzheimers Dement. 2013;9(6):649\u201356.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1866_CR50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.58591","volume":"8","author":"Z Wu","year":"2025","unstructured":"Wu Z, Cribb L, Wolfe R, Shah RC, Orchard SG, Owen A, et al. Cardiometabolic Trajectories Preceding Dementia in Community-Dwelling Older Individuals. JAMA Netw Open. 2025Feb 3;8(2):e2458591.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1866_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12779\/dnd.2022.21.1.30","volume":"21","author":"YS Mun","year":"2022","unstructured":"Mun YS, Park HK, Kim J, Yeom J, Kim GH, Chun MY, et al. Association between body mass index and cognitive function in mild cognitive impairment regardless of APOE \u03b54 status. Dement Neurocogn Disord. 2022;21(1):30\u201341.","journal-title":"Dement Neurocogn Disord"},{"key":"1866_CR52","unstructured":"The SPRINT MIND Investigators for the SPRINT Research Group. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321(6):553\u201361."},{"issue":"10452","key":"1866_CR53","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572\u2013628.","journal-title":"Lancet"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01866-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:03:36Z","timestamp":1759320216000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01866-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01866-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols and participants written informed consent was obtained and approved by the University of North Texas Health Science Center Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors grant consent to publish the manuscript in its finalized approved form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}